Genetic and RNA-related molecular markers of trastuzumab-chemotherapy-associated cardiotoxicity in HER2 positive breast cancer: a systematic review

Genetic and RNA-related molecular markers of trastuzumab-chemotherapy-associated cardiotoxicity in HER2 positive breast cancer: a systematic review

Cancer-therapy related cardiotoxicity (CTRCT) is a significant and frequent complication of monoclonal antibody directed therapy, especially Trastuzumab, for human epidermal growth factor receptor 2 (HER2) overexpressing breast cancers. Reliable, clinically available molecular predictive markers of...

Full description

Bibliographic Details
Main Authors: Abdelshafy, M. (Author), Al-Habbaa, A. (Author), Cawley, C. (Author), Crowley, J. (Author), Davey, M.G (Author), Elkoumy, A. (Author), Elzomor, H. (Author), Ganly, S. (Author), Kerin, M. (Author), Lowery, A. (Author), Lunardi, M. (Author), Sharif, F. (Author), Soliman, O. (Author), Wijns, W. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
Breast cancer
Cardiotoxicity
Genetic markers
HER2
miRNA
Polymorphisms
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items